Hits: 3
Carl Icahn has accused Illumina’s management and board of poor oversight, particularly with regard to the company’s acquisition of cancer test maker Grail. Read More Go To Source
News Ticker
- [ May 31, 2023 ] Advance Auto Parts shares plummet 30% after dismal results, cuts to outlook and dividend National
- [ May 31, 2023 ] Identity of Florida ‘Trunk Lady’ finally uncovered years after mom of 5 strangled with bolo tie National
- [ May 31, 2023 ] JPMorgan rejects claim that Dimon and Staley discussed Epstein: ‘We believe this is false’ National
- [ May 31, 2023 ] Washington state firefighters rescue 12-year-old boy who fell 20 feet down well National
- [ May 31, 2023 ] Pride flag burned at elementary school after concerns raised over its Pride event for children National
Copyright © 2020 | Fastinews.com
Be the first to comment